© Copyright RiverVest® All Rights Reserved.
MaxWell Biomedical acquired the assets of Cardialen to enhance its development-stage atrial pacing device for atrial fibrillation. MaxWell is developing he first device-based therapy designed to restore both sinus and atrial mechanical function without tissue destruction.
© Copyright RiverVest® All Rights Reserved.